Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1801 of 5804
-
New obesity drug spartina® put to the test in Real-World study
Disease control CompletedThe goal of this study is to evaluate Effectiveness and safety of Spartina® (Tirzepatide) in male or female participants with obesity and overweight. The main questions which are aimed to be answered: 1. Is Spartina® (Tirzepatide) effective in the treatment of obesity and overwe…
Sponsor: Cinnagen • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New device could help patients with Hard-to-Control blood pressure
Disease control Recruiting nowThe Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New egg-maturing technique could slash IVF costs and risks
Disease control Recruiting nowIn vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lower health risk profile of IVM compared to controlled ovarian stimulation (COS) …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New online treatments could ease prolonged grief
Symptom relief Recruiting nowThe main aim of this project is to test the efficacy of two formats of delivering an internet- based treatment(GROw) for Prolonged Grief Disorder (PGD) in order to enhance treatment adherence: in a blended format (that combines self-applied treatment online with face-to face sess…
Phase: NA • Sponsor: Universitat Jaume I • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New hope for hypothalamic obesity: Long-Term drug trial launches
Disease control ENROLLING_BY_INVITATIONThis is a long-term, open-label extension study of bivamelagon in participants with Hypothalamic Obesity (HO) who have transitioned from the index study, LG-MCCL005. The study will last up to 2 years.
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New skin test could reveal hidden cancer risks
Knowledge-focused Recruiting nowThe goal of this research study is to evaluate the feasibility of germline genetic testing using the investigational MyeloGen Gene Panel in adult participants diagnosed with myeloid malignancies.
Phase: NA • Sponsor: Christopher Reilly • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Could a simple pain shot improve IVF recovery without hurting success?
Symptom relief Recruiting nowKetorolac is a medication often used to relieve pain after surgery. In the past, infertility doctors have been cautious about using ketorolac after egg retrieval for patients planning a fresh embryo transfer (usually done 5 days later). The concern was that ketorolac might increa…
Phase: PHASE4 • Sponsor: Jessica D. Kresowik • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
No-Scar thyroid surgery tested against traditional neck cut
Symptom relief Recruiting nowNearly 50,000 thyroidectomies are performed in France each year for benign and malignant pathologies. Each one affects the life of the patient and represents, for some, suffering, symbolized by the stigma of the operation. The consequences of these scars vary according to the pat…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can a double-dose of quit-smoking meds help pancreatitis patients kick the habit?
Symptom relief TerminatedThe purpose of this research is to assess the effectiveness of two treatment strategies for smoking cessation in patients with acute recurrent pancreatitis or chronic pancreatitis who smoke cigarettes. All participants will receive varenicline, a commonly used medication that hel…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New hip implant aims to fix cartilage without replacement
Disease control Recruiting nowAny patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical interventi…
Phase: NA • Sponsor: Cytex Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a traditional chinese tablet reduce heart attacks and hospitalizations?
Disease control Recruiting nowA randomized controlled trial was conducted to evaluate the efficacy and safety of Yangxinshi tablets in improving the condition of patients with coronary heart disease complicated by cardiac dysfunction.
Phase: PHASE4 • Sponsor: SPH Qingdao Growful Pharmacetical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could stem cell 'messages' regrow hair? new trial begins.
Disease control Recruiting nowAndrogenic Alopecia(AGA) is a highly prevalent condition for which existing pharmacological and surgical interventions present limitations and side effects, creating a clinical need for safer and more effective therapies. In response, human umbilical cord mesenchymal stem cell-de…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immune boot camp: could a shingles vaccine ingredient supercharge your defenses?
Knowledge-focused Recruiting nowAs people grow older, their immune system - the body's natural defence against diseases - becomes weaker, making them more vulnerable to infections and less responsive to vaccines. This was clearly seen during the COVID-19 pandemic, where older adults were more likely to develop …
Phase: PHASE2 • Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Shock vs. pill: which works best for Kids' bladder issues?
Symptom relief Recruiting nowThe absence of infectious, urological and neurological causes defines the idiopathic character of overactive bladder (OAB). Although a progressive approach starting with behavioural therapy (urotherapy) is recommended, anticholinergic agents remain the mainstay of medical treatme…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Could less be more? new study tests lower doses of cancer drug
Disease control Recruiting nowBackground: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (atezolizumab) is approved to tr…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Booster shot study aims to strengthen meningitis b protection in young adults
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this clinical trial is to determine the immunogenicity of certain vaccines in protecting against meningitis B (MenB) in young adults who have previously received a different MenB vaccine. The main questions it aims to answer are: * How many participants are protecte…
Phase: PHASE4 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:06 UTC
-
Could less radiation be better for spine cancer?
Disease control Recruiting nowA single centre, non-profit, randomised, unblinded pilot study on volume definition for spinal stereotactic body radiation therapy treatment. Randomization will be 1:1 between two types of SBRT treatment for spinal metastases. The statistical unit will be the individual vertebra…
Phase: NA • Sponsor: IRCCS Sacro Cuore Don Calabria di Negrar • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Coaching may boost adherence to breast cancer therapy
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the effect of patient education and patient typology-based coaching on therapy persistence in breast cancer patients taking ribociclib. Researchers will compare the time to permanent treatment discontinuation of patients receiving pe…
Phase: NA • Sponsor: Institut fuer Frauengesundheit • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New asthma drug shows promise in early human trials
Symptom relief Recruiting nowPhase 1 of this study will consist of 2 parts * Part 1 will evaluate the safety, tolerability, pharmacokinetics and immunogenicity of PRA-216 in healthy volunteers through single ascending dose administered by either intravenous (IV) or subcutaneous (SC). * Part 2 will evaluate …
Phase: PHASE1, PHASE2 • Sponsor: Prana Therapies Inc • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New imaging agent aims to spot Hard-to-Find tumors
Diagnosis Recruiting nowPrecision medicine represents a major goal in oncology. It has its underpinning in the identification of biomarkers with diagnostic, prognostic, or predictive values. Gastro-entero-pancreatic neuroendocrine neoplasia (GEP-NENs) are rare tumors, but their frequency is increasing. …
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC